nnc9204-0530
Peptideexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Sep 4, 2014 (NCT02235961)
Timeline
2010s
- Jan 1, 2014
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Glucagon receptorAGONIST
GCGR agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- nnc9204-0530
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02870231 | Phase 1 | Aug 18, 2016 | Novo Nordisk |
| NCT02835235 | Phase 1 | Jul 26, 2016 | Novo Nordisk |
| NCT02235961 | Phase 1 | Sep 4, 2014 | Novo Nordisk |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Novo Nordisk | For profit | 3 | 3 | 1 | 2014 |
1 organizations
Page 1 / 1